Skip to main content

Table 2 Comparison of basic characteristics of people with and without hepatic fibrosis

From: Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome

Variables

Total (n = 876)

Non-hepatic fibrosis group (n = 725)

Hepatic fibrosis group (n = 151)

P

Age, years, Mean (S.E)

52.37 (1.18)

52.11 (1.14)

53.83 (2.24)

0.379

Gender, n (%)

   

0.687

 Male

407 (50.07)

325 (50.58)

82 (47.24)

 

 Female

469 (49.93)

400 (49.42)

69 (52.77)

 

Race, n (%)

   

0.606

 Mexican American

154 (11.52)

128 (11.30)

26 (12.75)

 

 Other Hispanic

96 (6.79)

76 (6.25)

20 (9.84)

 

 Non-Hispanic White

308 (62.25)

254 (62.50)

54 (60.90)

 

 Non-Hispanic Black

162 (8.86)

138 (9.23)

24 (6.83)

 

 Other Race

156 (10.58)

129 (10.73)

27 (9.69)

 

Education level, n (%)

   

0.248

 High school degree or less

222 (15.10)

191 (15.54)

31 (12.68)

 

 High school education

214 (32.53)

176 (31.26)

38 (39.69)

 

 High school degree or above

429 (51.71)

351 (52.67)

78 (46.34)

 

 Unknown

11 (0.65)

7 (0.53)

4 (1.30)

 

Family PIR, Mean (S.E)

2.80 (0.10)

2.86 (0.11)

2.45 (0.16)

0.040

Drinking status, n (%)

   

0.031

 No

116 (9.73)

93 (8.52)

23 (16.51)

 

 Yes

760 (90.27)

632 (91.48)

128 (83.49)

 

Smoking status, n (%)

   

0.556

 Never smoked

457 (49.28)

391 (50.05)

66 (44.98)

 

 Used to smoke and now quit

255 (30.88)

200 (29.90)

55 (36.34)

 

 Still smoking

164 (19.85)

134 (20.05)

30 (18.68)

 

Physical activity, n (%)

   

0.092

 ≤ 750 MET∙ min

605 (61.46)

495 (59.54)

110 (72.21)

 

 > 750 MET∙ min

271 (38.54)

230 (40.46)

41 (27.79)

 

SBP, mmHg, Mean (S.E)

131.37 (0.63)

131.38 (0.67)

131.31 (2.01)

0.974

DBP, mmHg, Mean (S.E)

76.09 (0.64)

76.75 (0.75)

72.36 (1.48)

0.023

Hepatitis, n (%)

   

0.345

 No

797 (93.57)

663 (94.18)

134 (90.18)

 

 Yes

79 (6.43)

62 (5.82)

17 (9.83)

 

CKD, n (%)

   

0.055

 No

811 (95.27)

678 (95.80)

133 (92.32)

 

 Yes

65 (4.73)

47 (4.20)

18 (7.68)

 

CVD, n (%)

   

0.013

 No

592 (71.57)

506 (74.23)

86 (56.71)

 

 Yes

284 (28.43)

219 (25.77)

65 (43.29)

 

ALT, U/L, Mean (S.E)

27.25 (1.04)

25.62 (0.99)

36.35 (3.05)

0.003

AST, U/L, Mean (S.E)

23.48 (0.81)

22.03 (0.73)

31.56 (3.27)

0.011

ALP, IU/L, Mean (S.E)

81.61 (0.83)

80.95 (1.10)

85.32 (3.74)

0.334

GGT, IU/L, Mean (S.E)

36.13 (1.94)

32.75 (1.57)

55.06 (6.87)

0.005

TC, mg/dL, Mean (S.E)

191.01 (3.62)

191.97 (3.35)

185.58 (6.05)

0.153

LDL-C, mg/dL, Mean (S.E)

114.49 (2.57)

115.17 (2.32)

110.62 (5.13)

0.281

Hs-CRP, mg/L, Mean (S.E)

5.22 (0.50)

4.95 (0.57)

6.71 (1.09)

0.174

Platelet count, 1000 cells/uL, Mean (S.E)

245.33 (3.66)

247.28 (4.06)

234.42 (4.97)

0.031

Total bilirubin, umol/L, Mean (S.E)

8.12 (0.24)

8.01 (0.25)

8.70 (0.37)

0.087

Serum creatinine, mg/dL, Mean (S.E)

0.87 (0.01)

0.87 (0.01)

0.87 (0.03)

0.892

Urinary creatinine, mg/dL, Mean (S.E)

139.13 (5.45)

139.34 (6.58)

137.99 (12.73)

0.933

Serum ALB, g/L, Mean (S.E)

39.79 (0.26)

39.96 (0.23)

38.85 (0.47)

0.008

Urinary ALB, mg/L, Mean (S.E)

57.03 (8.94)

45.93 (7.36)

119.26 (32.68)

0.036

Drug for diabetes, n (%)

   

< 0.001

 No

634 (77.36)

553 (80.49)

81 (59.81)

 

 Yes

242 (22.64)

172 (19.51)

70 (40.19)

 

Drug for hypertension, n (%)

   

0.329

 No

472 (57.54)

409 (59.01)

63 (49.30)

 

 Yes

404 (42.46)

316 (40.99)

88 (50.71)

 

Drug for dyslipidemia, n (%)

   

0.934

 No

591 (69.83)

500 (69.76)

91 (70.23)

 

 Yes

285 (30.17)

225 (30.24)

60 (29.77)

 

Antiviral agents, n (%)

    

 No

874 (99.92)

723 (99.91)

151 (100.00)

 

 Yes

2 (0.08)

2 (0.10)

0 (0.00)

 

Glucocorticoids, n (%)

   

0.018

 No

854 (97.73)

705 (97.42)

149 (99.45)

 

 Yes

22 (2.27)

20 (2.58)

2 (0.55)

 

Drug induce hepatic steatosis n (%)

   

0.666

 No

859 (97.67)

710 (97.81)

149 (96.84)

 

 Yes

17 (2.33)

15 (2.19)

2 (3.16)

 

Energy, Mean (S.E)

2220.76 (50.98)

2230.40 (53.05)

2166.76 (106.88)

0.565

Carbohydrate, Mean (S.E)

258.88 (6.21)

261.61 (6.74)

243.59 (15.49)

0.304

Protein, Mean (S.E)

83.54 (2.04)

83.31 (2.41)

84.85 (5.29)

0.809

Total fat, Mean (S.E)

91.19 (2.41)

91.22 (2.66)

91.03 (4.93)

0.972

Vitamin E, Mean (S.E)

0.67 (0.18)

0.70 (0.21)

0.53 (0.28)

0.629

METS-IR, Mean (S.E)

53.19 (1.03)

51.64 (0.84)

61.89 (1.92)

< 0.001

TyG index, Mean (S.E)

9.14 (0.04)

9.11 (0.05)

9.27 (0.07)

0.097

HOMA-IR, Mean (S.E)

6.49 (0.37)

5.76 (0.30)

10.56 (1.98)

0.036

TyG-WHtR, Mean (S.E)

6.05 (0.07)

5.92 (0.06)

6.79 (0.12)

< 0.001

  1. PIR income-to-poverty ratio, SBP systolic blood pressure, DBP diastolic blood pressure, CKD chronic kidney disease, CVD cardiovascular disease, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, GGT gamma glutamyl transferase, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, ALB albumin, METS-IR metabolic score for insulin resistance, TyG triglyceride/glucose, HOMA-IR homeostasis model assessment of IR, TyG-WHtR triglyceride glucose-waist-to-height ratio